Company news

Teleflex Incorporated news in 2026

Teleflex Incorporated's news releases, calls and decks from 2026, newest first.

View company

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold

October 22, 2026

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information

October 22, 2026

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold

October 12, 2026

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

September 29, 2026

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

September 8, 2026

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

September 4, 2026

Q2 2026 Teleflex Incorporated Earnings Call Presentation

August 6, 2026

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

August 6, 2026

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

August 4, 2026

Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

August 3, 2026

Teleflex Announces FDA BLA Approval of EZPLAZ Freeze Dried Plasma

July 30, 2026

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

July 29, 2026

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

July 23, 2026

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

July 21, 2026

Teleflex Publishes 2025 Global Impact Report

July 7, 2026

Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

June 23, 2026

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

June 1, 2026

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

June 1, 2026

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

May 21, 2026

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

May 7, 2026

Teleflex Appoints Jason Weidman as President and CEO

April 30, 2026

Teleflex Announces First Quarter 2026 Earnings Conference Call Information

April 23, 2026

Teleflex Announces Governance Updates

April 9, 2026

Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution

March 27, 2026

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

March 12, 2026

Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

February 26, 2026

Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

February 17, 2026

Teleflex Announces Leadership Transition

January 8, 2026

Calls in 2026

Decks in 2026